Advance On Ventures Limited holds 109,200 Advanced Biomed shares, equal to 6.6% ownership. The structure matters to investors because Chen Yi Lee has sole voting and dispositive power over those shares and also directly holds 14,640 shares, for a reported 7.5% position.
Key Highlights
- Advanced Biomed’s ownership percentages are based on 1,652,133 common shares outstanding as of May 29, 2026.
- Chen Yi Lee’s reported position totals 123,840 shares, or 7.5% of Advanced Biomed.
- Advance On Ventures Limited is organized in the British Virgin Islands and has its principal Business address in Taiwan.
Advanced Biomed Inc. (NASDAQ: ADVB) is a biotechnology company. Advance On Ventures Limited holds 109,200 shares of Advanced Biomed common stock, representing 6.6% ownership.
Ownership Basis and Reporting Parties
The jointly submitted ownership statement identifies Advance On Ventures Limited and Chen Yi Lee as the reporting persons. The percentage calculation uses 1,652,133 Advanced Biomed common shares outstanding as of May 29, 2026, a figure reported in the company’s definitive proxy statement filed June 4, 2026. The security is common stock with a Par Value of $0.001 per share. Advance On Ventures Limited was organized in the British Virgin Islands, while its principal business address and Chen Yi Lee’s principal business address are in Taiwan.
Chen Yi Lee Holds Voting Control
Advance On Ventures Limited is the registered holder of its reported shares, and Chen Yi Lee has sole voting and dispositive authority over that holding as the company’s sole director. Chen Yi Lee also owns 14,640 Advanced Biomed shares directly, consisting of 14,625 shares acquired before the initial public offering and 15 shares bought in the open market afterward. The combined reported position is 123,840 shares, equal to 7.5% ownership. The ownership statement was submitted under Rule 13d-1(d).
FAQs
Q: How much of Advanced Biomed does Advance On Ventures own?
A: Advance On Ventures Limited is reported as holding 109,200 shares of Advanced Biomed common stock, representing 6.6% ownership. The percentage uses 1,652,133 shares outstanding as of May 29, 2026.
Q: What is Chen Yi Lee’s Advanced Biomed stake?
A: Chen Yi Lee’s reported position is 123,840 Advanced Biomed shares, equal to 7.5% ownership. The total includes shares held through Advance On Ventures Limited and shares owned directly.
Q: Who controls Advance On Ventures’ Advanced Biomed shares?
A: Chen Yi Lee has sole voting and dispositive power over the shares recorded in Advance On Ventures Limited’s name. Chen also directly owns 14,640 Advanced Biomed shares.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.